The emerging role of the mitochondrial-derived peptide humanin in stress resistance.
Yen. Kelvin K; Lee. Changhan C; Mehta. Hemal H; Cohen. Pinchas P
Key Findings
- Humanin is a mitochondrial‑derived peptide that protects cells from oxidative stress, serum starvation, and hypoxia in vitro
- In animal models humanin improves cardiovascular disease outcomes and reduces Alzheimer’s‑related pathology
- The peptide’s stress‑resistance effects are emerging as a key mechanism for its potential health benefits
Practical Outcomes
- Humanin looks promising for boosting stress resistance and possibly supporting heart and brain health, but it’s still early‑stage research. No clear dosage or supplement form is established yet, so biohackers should watch for upcoming clinical trials before adding it to protocols.
Summary
Humanin is a small protein made by mitochondria that helps cells survive stress like oxidative damage, low oxygen, and nutrient shortage. In animal studies it also appears to improve heart health and reduce signs of Alzheimer’s disease. The paper is a review, so it doesn’t give specific dosing or protocols, but it highlights humanin as a potentially useful molecule for protecting against cellular stress and age‑related diseases.
Abstract
The discovery of humanin, a novel, mitochondrial-derived peptide, has created a potentially new category of biologically active peptide. As more research unravels the endogenous role of humanin as well as its potential pharmacological use, its role in stress resistance has become clearer. Humanin protects cells from oxidative stress, serum starvation, hypoxia, and other insults in vitro and also improves cardiovascular disease as well as Alzheimer's disease in vivo. In this review, we discuss the emerging role of humanin in stress resistance and its proposed mechanism of action.
Study Information
pubmed
2013
2013-01-11T00:00:00.000Z
10.1530/jme-12-0203